New BTK Inhibitor Pirtobrutinib Shows Promise in CLL

New BTK Inhibitor Pirtobrutinib Shows Promise in CLL

Pirtobrutinib treatment yielded promising outcomes in chronic lymphocytic leukemia (CLL) and other p...
read more
Coronavirus ‘fatigue is winning’ as decline in cases, deaths stalls, CDC’s Walensky warns

Coronavirus ‘fatigue is winning’ as decline in cases, deaths stalls, CDC’s Walensky warns

COVID-19 vaccines, recovery will be ‘quite posit...
read more
TBE patients continue to be affected by long-term problems

TBE patients continue to be affected by long-term problems

Impaired memory, reduced motivation, and declining...
read more
Locilan

Locilan

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Remicade

Remicade

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Blooms the Chemist Escitalopram

Blooms the Chemist Escitalopram

NOTICE: This Consumer Medicine Information (CMI) i...
read more
Chronic fatigue syndrome – is Often undetected and, unfortunately, belittled disease

Chronic fatigue syndrome – is Often undetected and, unfortunately, belittled disease

To the incurable disease „Chronic Erschöpfu...
read more
Burnout research: Overactive immune system the cause of chronic fatigue syndrome

Burnout research: Overactive immune system the cause of chronic fatigue syndrome

Experts find cause of chronic fatigue syndrome The...
read more